Our Individual Genome Sequencing (IGS) Team

Tina Hambuch, PhD

Tina Hambuch is the Scientific Liaison to Illumina’s Clinical Laboratory. She earned her Bachelor’s degree from UC Riverside and her doctorate from UC Berkeley, focusing on genetic analyses of genes that control the immune system. She continued her studies of genetic variation as a post-doctoral fellow at the Centers for Disease Control and an assistant professor at the Ludwig Maximillians University in Munich. After her academic career, Tina used her understanding of genetics and genetic variation to help identify and design diagnostic sequencing tests for clinical application at Ambry Genetics. Tina joined Illumina in 2008 where she combined her experience in genetics, genomics, and clinical diagnostics to contribute to the development of the CLIA-certified, CAP-accredited Illumina Clinical Services Laboratory (ICSL). In 2010, she launched a California-certified Clinical Genetic Molecular Biologist Scientist training program in which she serves as the Education Coordinator and Director. Tina is currently active in the development and validation of genetic testing, as well as clinical tools for doctor support and education. Tina is a member of the American College of Medical Genetics and the American Society of Human Genetics.

Marc Laurent, MBA

Marc Laurent is the Director of Commercial Services at Illumina. He received his Masters in Engineering from Ecole Nationale Supérieure d'Arts et Métiers in Paris, France and his MBA from the Haas School of Business at UC Berkeley with Certificates in Entrepreneurship and Management of Technology. After working in the automation, aerospace, and medical devices industries, he joined Illumina in 2001 where he participated in the development of the BeadLab and BeadStation instruments. Marc has led Commercial Services at Illumina since 2005. In this capacity, he manages FastTrack Genotyping Services, which has genotyped over 600,000 samples, including samples for the HapMap Project and over 60 GWAS studies. He also oversaw the establishment of Illumina Clinical Laboratory Services as part of Commercial Services, obtaining CLIA certification and CAP accreditation for human whole-genome sequencing, and producing the first human genome under CLIA certification in June 2009.

Julianne O'Daniel, MS, CGC

Julianne O'Daniel is the Clinical Genomics Liaison for the Individual Genome Sequencing service and a certified genetic counselor. She is a graduate of the University of Pittsburgh genetic counseling program. Prior to joining Illumina in early 2010, she was an Associate in Research within the Duke Institute for Genome Sciences & Policy, as well as a practicing genetic counselor in the Duke Executive Health Program. With over 10 years of experience, her research and clinical work has centered on the impact and delivery of genetic and genomic risk information, including the development of educational resources. Julianne has also been the Principle and Co-Investigator on several federally funded grant projects and has published articles and book chapters as well as lectured internationally on the topics of risk communication and genomic medicine. Julianne is active in several professional organizations and is currently the Education Vice Chair for the National Society of Genetic Counselors.

Jerry Spector, MBA

Jerry Spector is the Associate Director of Alliances within the Business Development group at Illumina. He received his Bachelor’s degree from the University of Kansas and his MBA from the Fuqua School of Business at Duke University. He has experience in the biotechnology and pharmaceutical industries in sales, market research, and product marketing. In 2007, Jerry joined Illumina where he currently enables and leads alliance opportunities in Applied Markets.